Literature DB >> 1402690

Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells.

C H Chang1, W L Fodor, R A Flavell.   

Abstract

Terminally differentiated plasma cells and mouse T cells do not express major histocompatibility complex (MHC) class II genes although class II gene expression is observed in pre-B and mature B cells as well as in activated human T cells. Transient heterokaryons were prepared and analyzed to investigate the mechanisms of inactivation of MHC class II gene in mouse plasmacytoma cells and mouse T cells. The endogenous MHC class II genes in both mouse plasmacytoma cells and mouse T cells can be reactivated by factors present in B cells. This reactivation of class II gene is also observed by fusion with a human T cell line which expresses MHC class II genes, but not with a class II negative human T cell line. It appears that the loss of MHC class II gene expression during the terminal differentiation of B cells or T cell lineage is due to absence of positive regulatory factor(s) necessary for class II transcription.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402690      PMCID: PMC2119411          DOI: 10.1084/jem.176.5.1465

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Endocytosis of MHC molecules by B cell-B lymphoma and B cell-T lymphoma hybrids.

Authors:  D Aragnol; B Malissen; C Schiff; M A Piron; L D Leserman
Journal:  J Immunol       Date:  1986-11-15       Impact factor: 5.422

2.  In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome.

Authors:  C J Kara; L H Glimcher
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

3.  HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.

Authors:  B Gansbacher; K S Zier
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Expression of HLA-DR mRNA in T cells following activation is early and can precede DNA synthesis.

Authors:  K Zier; B Gansbacher; N Ikegaki; R Kennett; K Polakova
Journal:  Autoimmunity       Date:  1989       Impact factor: 2.815

5.  Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.

Authors:  J Guardiola; L Scarpellino; G Carra; R S Accolla
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Cytoplasmic activation of human nuclear genes in stable heterocaryons.

Authors:  H M Blau; C P Chiu; C Webster
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

7.  Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function.

Authors:  G Widera; L C Burkly; C A Pinkert; E C Böttger; C Cowing; R D Palmiter; R L Brinster; R A Flavell
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

8.  Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells.

Authors:  P Dellabona; F Latron; A Maffei; L Scarpellino; R S Accolla
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

9.  The complete nucleotide sequence of the I-E alpha d immune response gene.

Authors:  J J Hyldig-Nielsen; L Schenning; U Hammerling; E Widmark; E Heldin; P Lind; B Servenius; T Lund; R Flavell; J S Lee; J Trowsdale; P H Schreier; F Zablitzky; D Larhammar; P A Peterson; L Rask
Journal:  Nucleic Acids Res       Date:  1983-08-11       Impact factor: 16.971

10.  Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Authors:  Z Yang; R S Accolla; D Pious; B J Zegers; J L Strominger
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  8 in total

Review 1.  The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

Authors:  A DeSandro; U M Nagarajan; J M Boss
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  B cell differentiation is associated with reprogramming the CCCTC binding factor-dependent chromatin architecture of the murine MHC class II locus.

Authors:  Parimal Majumder; Christopher D Scharer; Nancy M Choi; Jeremy M Boss
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

3.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

4.  Increased gamma-delta T-lymphocyte response to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice.

Authors:  D Muller; P Pakpreo; J Filla; K Pederson; F Cigel; V Malkovska
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  The Murine MHC Class II Super Enhancer IA/IE-SE Contains a Functionally Redundant CTCF-Binding Component and a Novel Element Critical for Maximal Expression.

Authors:  Parimal Majumder; Joshua T Lee; Benjamin G Barwick; Dillon G Patterson; Alexander P R Bally; Christopher D Scharer; Jeremy M Boss
Journal:  J Immunol       Date:  2021-04-16       Impact factor: 5.422

6.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

Authors:  P Silacci; A Mottet; V Steimle; W Reith; B Mach
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

7.  Characterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium.

Authors:  S E Albert; F Strutz; K Shelton; T Haverty; M J Sun; S R Li; A Denham; R A Maki; E G Neilson
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

8.  A super enhancer controls expression and chromatin architecture within the MHC class II locus.

Authors:  Parimal Majumder; Joshua T Lee; Andrew R Rahmberg; Gaurav Kumar; Tian Mi; Christopher D Scharer; Jeremy M Boss
Journal:  J Exp Med       Date:  2020-02-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.